Tuberculosis News and Research

Latest Tuberculosis News and Research

UTA chemist to develop simple, paper-based test for drug-resistant TB

Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.

23 Dec 2011

'Global Pulse' blog examines declining TB incidence in Estonia

In this post in GlobalPost's "Global Pulse" blog, journalist John Donnelly reports on tuberculosis (TB) in Estonia and how the country has significantly reduced the proportion of multi-drug resistant tuberculosis (MDR-TB) cases since 1998. He writes, "The numbers of new TB cases in Estonia were five times that of the Nordic countries in 1998, but the numbers have tumbled since then and last year Estonia had cut that in half, to 2.5 times the number."

22 Dec 2011

Global Fund Board must 'sound alarm' to renew funding commitments

In an opinion piece on the Medecins Sans Frontieres (MSF) website, MSF International President Unni Karunakara writes that with the cancellation of the Global Fund To Fight AIDS, Tuberculosis and Malaria's Round 11 grants, "The Board of the Global Fund must raise the alarm. Instead of accepting rationing, and cancelling ambitions, we urge the Global Fund Board to organize an emergency donor conference to renew commitment and allow countries where the diseases are endemic to apply for funding in 2012."

21 Dec 2011

UCB initiates EXXELERATE study in rheumatoid arthritis

UCB today announced the start of the EXXELERATE study which will evaluate the short- and long-term efficacy of Cimzia (certolizumab pegol) plus methotrexate (MTX) compared with that of Humira(adalimumab) plus MTX in the treatment of moderate to severe rheumatoid arthritis (RA). The start of this study confirms previously announced plans.

21 Dec 2011

Global health aid continues to grow despite recession, report indicates

"Spending to improve health in developing countries has continued to grow during the three-year economic downturn, although at only half the blistering pace it did a decade ago," according to a report by researchers at the University of Washington's Institute for Health Metrics and Evaluation (IHME), the Washington Post reports.

16 Dec 2011

Global Fund releases 'Information Note' on Transitional Funding Mechanism

The Center for Global Health Policy's "ScienceSpeaks" blog reports on a recently released "Information Note" from the Global Fund to Fight AIDS, Tuberculosis and Malaria "explaining the Transitional Funding Mechanism (TFM) that the Fund Board recently decided would replace a Round 11 funding cycle.

16 Dec 2011

Study aims to reduce mortality disparities by education

A study in the December issue of the American Sociological Review has brought new understanding as to why death rates for less educated middle aged adults are much higher than for their more educated peers despite increased awareness and treatments aimed at reducing health disparities.

16 Dec 2011

Gates Foundation, Grand Challenges to develop new diagnostics for tropical diseases

Grand Challenges Canada and the Bill & Melinda Gates Foundation have teamed up on an unprecedented global effort to discover and develop affordable, easy-to-use tools to help developing country health workers rapidly diagnose diseases in rural communities. The expected result: more timely and appropriate treatment of illnesses in poor countries, potentially saving countless lives.

16 Dec 2011

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.

15 Dec 2011

Goal of near-zero malaria deaths attainable with continued will, resources

In this TIME "Ideas" opinion piece, David Bowen, CEO of Malaria No More, writes that with the right resources and political will, an end to malaria is possible.

15 Dec 2011

Paul Farmer discusses equity in international health with Scientific American

In this Scientific American "60-Second Health" podcast, journalist Katherine Harmon interviews Paul Farmer, a Harvard professor and co-founder of the non-profit Partners in Health, who is "famous for his health work in Haiti."

15 Dec 2011

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

15 Dec 2011

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.

14 Dec 2011

Research describes advantages of new vaccine adjuvant

New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.

13 Dec 2011

Incidence of TB diagnosis is increased in mothers postpartum

The incidence of tuberculosis (TB) diagnosis is significantly increased in mothers postpartum, suggesting a potential new population to target for screening, according to a new UK-wide cohort study.

12 Dec 2011

New guidelines for managing latent tuberculosis from CDC

The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called “latent” tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.

11 Dec 2011

Progress in AIDS fight in peril as governments renege on funding pledges

In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."

9 Dec 2011

MCC invests $122M in Lesotho health system to address key challenges, including HIV, TB

"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.

9 Dec 2011

Shorter, effective treatment for latent TB infection

Research, led by Timothy Sterling, M.D., professor of Medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis (TB).

9 Dec 2011

Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed an agreement with Pharmacyclics, Inc. to jointly develop and market the anti-cancer compound, PCI-32765.

9 Dec 2011